Dual specificity phosphatase 6 is a novel therapeutic target in neuroendocrine tumors
Majid Momeny, PhD
Active Projects
Efficient automated synthesis of silicon-[18F]fluoride acceptor (SiFA)-based neuroendocrine tumour imaging agents via “non-anhydrous, minimally basic” (NAMB) radio-fluorination chemistry.
James Inkster, PhD
Elucidating the mechanisms for resistance to antiangiogenic therapy and metastasis in PanNETs
Yeonghwan Kim, PhD
Elucidating the origin of pulmonary carcinoids and molecular diversity of human neuroendocrine cells
Christin Kuo, MD
Elucidating the role of aging in GEP-NET development
Suzann Duan, PhD
Establishing & characterizing a pancreatic neuroendocrine tumor mouse model with humanized telomeres
Daniel Schramek, PhD
Exploring new therapeutic avenues for SDHB-deficient metastatic PPGL
Qianjin Guo, PhD
Finding the causes of small intestinal neuroendocrine tumors
Matthew Meyerson, MD, PhD; Eric Nakakura, MD, PhD; Chrissie Thirlwell, MD, PhD
Glycomic characterization of pancreatic neuroendocrine neoplasms
Sharon Gorski, PhD
Harnessing ferroptosis initiating drugs to target GEP-NETs
Jeffrey Frost, PhD